Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice

Autor: Baomin Fan, Haitao Xiao, Zhaoxiang Bian, Lidan Zhong, Ze Si Lin, Chengyuan Lin, Tao Huang, Huai Xue Mu, Ling Zhao, Guang Zhi Zeng
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Indoles
Interleukin-1beta
Pharmaceutical Science
Pharmacology
Kynurenic Acid
Inflammatory bowel disease
Analytical Chemistry
magnolol
inflammation
ulcerative colitis
tryptophan metabolites
Mice
chemistry.chemical_compound
Kynurenic acid
Drug Discovery
biology
Dextran Sulfate
Colitis
Ulcerative colitis
Magnolol
Biphenyl compound
Biochemistry
Chemistry (miscellaneous)
Myeloperoxidase
Molecular Medicine
Lignans
Article
lcsh:QD241-441
03 medical and health sciences
lcsh:Organic chemistry
medicine
Animals
Physical and Theoretical Chemistry
Indoleacetic Acids
Interleukin-6
Tumor Necrosis Factor-alpha
Biphenyl Compounds
Organic Chemistry
Polyphenols
biology.organism_classification
medicine.disease
digestive system diseases
Mice
Inbred C57BL

Magnolia officinalis
030104 developmental biology
chemistry
biology.protein
Zdroj: Molecules; Volume 22; Issue 7; Pages: 1218
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 22, Iss 7, p 1218 (2017)
ISSN: 1420-3049
DOI: 10.3390/molecules22071218
Popis: Magnolol is a lignan with anti-inflammatory activity identified in Magnolia officinalis. Ulcerative colitis (UC), one of the types of inflammatory bowel disease (IBD), is a disease that causes inflammation and ulcers in the colon. To investigate the effect of magnolol in dextran sulfate sodium (DSS)-induced experimental UC model, male C57 mice were treated with 2% DSS drinking water for 5 consecutive days followed by intragastric administration with magnolol (5, 10 and 15 mg/kg) daily for 7 days. The results showed that magnolol significantly attenuated disease activity index, inhibited colonic shortening, reduced colonic lesions and suppressed myeloperoxidase (MPO) activity. Moreover, colonic pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) induced by colitis were dramatically decreased by magnolol. To further unveil the metabolic signatures upon magnolol treatment, mass spectrometry-based metabolomic analysis of the small molecular metabolites in mice serum were performed. Compared with controls, abnormality of serum metabolic phenotypes in DSS-treated mice were effectively reversed by different doses of magnolol. In particular, magnolol treatment effectively elevated the serum levels of tryptophan metabolites including kynurenic acid (KA), 5-hydroxyindoleacetic acid, indoleacetic acid (IAA), indolelactic acid and indoxylsulfuric acid, which are potential aryl hydrocarbon receptor (AHR) ligands to impact colitis. These findings suggest that magnolol exerts anti-inflammatory effect on DSS-induced colitis and its underlying mechanisms are associated with the restoring of tryptophan metabolites that inhibit the colonic inflammation.
Databáze: OpenAIRE